Device / Technology News

RSS

FDA approves Nordion's TheraSphere IDE for Phase III trial to treat HCC

Nordion Inc., a leading provider of products and services to the global health science market, today announced that it has received U.S. Food and Drug Administration approval to conduct a Phase III clinical trial for TheraSphere® under an Investigational Device Exemption.

23 Mar 2011

Almac to launch new services for clinical trial patient management

Almac announced today that its Clinical Technologies business unit, a global leader in clinical trial management, will launch a suite of new services designed to improve patient compliance and retention in clinical trials.

23 Mar 2011

Winner Medical's spunlace non-woven fabric technology wins Circular Economy Project Award

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, proudly announced today that its wholly owned subsidiary, Winner Industries Co., Ltd., was the only medical device manufacturing company to win the Circular Economy Project Award for the year 2010.

23 Mar 2011

GoodTherapy.org launches new syndicated advice-column for psychotherapy problems

GoodTherapy.org recently launched its new, syndicated bi-weekly column "Dear GoodTherapy.org"; aimed at answering real questions for real peoples' problems about psychotherapy, marriage counseling and mental health issues.

23 Mar 2011

Researchers create nanosurfaces to seal leg prosthetics against bacteria entry

In recent years, researchers have worked to develop more flexible, functional prosthetics for soldiers returning home from battlefields in Afghanistan or Iraq with missing arms or legs. But even new prosthetics have trouble keeping bacteria from entering the body through the space where the device has been implanted.

23 Mar 2011

More sensitive test to detect protein troponin associated with increased diagnosis of heart attacks

In patients with a suspected acute coronary syndrome (ACS; such as heart attack or unstable angina), use of a more sensitive test to detect the protein troponin in blood was associated with increased diagnosis of a heart attack and improved identification of patients at high risk of another heart attack and death in the following year, according to a study in the March 23/30 issue of JAMA.

23 Mar 2011

Asuragen introduces CE-mark approved AmplideX FMR1 PCR Kit

Asuragen, Inc. announced that they have achieved CE-marking and commercial launch in Europe of the AmplideX FMR1 PCR Kit for the detection of CGG repeats in the fragile X mental retardation gene.

23 Mar 2011

LDR submits two-level Mobi-C cervical artificial disc PMA to the FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.

23 Mar 2011

Bowel cancer rate increases to 12% in over 60s in England due to screening test

Bowel cancer rates in 60 to 69 year olds went up by more than 12 per cent in England from 2006 to 2008, according to the latest figures from Cancer Research UK.

23 Mar 2011

HTH relaunches new consumer e-commerce site

HTH Worldwide, a global health and safety services company, today announced the relaunch of its consumer e-commerce site, hthtravelinsurance.com. HTH redesigned the user experience with a focus on allowing customers to quickly find the medical or travel protection products that meet their needs.

23 Mar 2011

SimQuest develops open-incision surgical simulation platform

SimQuest LLC, a leading developer of technology-assisted education and training, has developed the first platform for open-incision surgical simulation, which will enable surgeons to practice open surgical techniques with no risk to patients. The platform will allow surgeons to practice their skills in an environment that allows for errors and provide objective feedback on performance.

23 Mar 2011

UDL enters license agreement with Humeca for burn, wound care products

Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.

23 Mar 2011

NeoTract initiates patient enrollment for UroLift System trial to treat prostrate cancer

NeoTract, Inc. a medical device company focused on developing urology devices, today announced that the first U.S. patients have been enrolled in a multinational trial of its UroLift® System at Western Urological Clinic in Salt Lake City, Utah.

23 Mar 2011

CABC offers first-ever PEM-guided accessory for breast biopsy

The Center for Advanced Breast Care is the first comprehensive breast center in the Chicago area to add Positron Emission Mammography-guided biopsy capability to its already extensive breast cancer care services.

23 Mar 2011

$FDA clears LensAR Laser System for use in refractive cataract surgery$

FDA clears LensAR Laser System for use in refractive cataract surgery

LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced today that the company has received 510(k) clearance from the FDA for use of the LensAR™ Laser System for anterior capsulotomy and lens fragmentation during cataract surgery.

23 Mar 2011

New image resolution technology from Ellex ELX

Ellex Medical Lasers Limited (ASX:ELX), an ophthalmic laser and ultrasound technology company, today announced that it will introduce a new diagnostic ultrasound mode for its leading Eye Cubed™ system at the upcoming meeting of the American Society of Cataract and Refractive Surgeons Meeting.

22 Mar 2011

Researchers launch free online Atlas of TB vaccination policies around the world

Tuberculosis continues to pose a major global health threat. Someone in the world is newly infected with TB bacteria every second. Every year, more than 9 million people develop active TB and it claims about 2 million lives.

22 Mar 2011

Isogenica executes services agreement with J&JPRD

Isogenica Ltd today announced that it has executed a services agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

22 Mar 2011

UCSD selects Millennium Labs, Research Institute for NIAAA granted study

Millennium Laboratories, a leading provider of therapeutic drug monitoring, research and healthcare education, and the Millennium Research Institute, a national non-profit research center, announced today they have been selected by the University of California, San Diego School of Medicine to provide laboratory services, including research and analysis, for a new UC San Diego study funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

22 Mar 2011

Objet demonstrates 3D printing solution benefits for digital dentistry at IDS

As digital dentistry becomes a standard production tool for many dental practices and laboratories, Objet Geometries Ltd. demonstrates the benefits of adding 3D printing to the workflow at IDS.

22 Mar 2011